6th International Conference on Cancer Science and Therapy

The "Cancer Research Therapy and Autoimmune Diseases" session will focus on the intersection of cancer research and autoimmune disorders, exploring how advances in cancer therapies can influence autoimmune conditions, and vice versa. Recent research has revealed intriguing connections between cancer and autoimmune diseases. In both cases, the immune system plays a critical role, either failing to prevent cancer or mistakenly attacking the body’s own tissues in autoimmune diseases. This session will delve into the biological pathways that overlap between these conditions, highlighting how understanding these links can lead to innovative treatment approaches.

The session on Cancer Biology and Biomarkers offers a deep dive into how normal cells undergo malignant transformation and how biomarkers can provide crucial insights into cancer detection and treatment and provide an experience designed for researchers, clinicians, and students eager to deepen their understanding of cancer biology and the emerging role of biomarkers in diagnosis and therapy.

Cancer Biology: Explore the molecular and cellular mechanisms that drive the transition of normal cells into cancerous ones. This session will discuss how disruptions in a cell’s intracellular network lead to carcinogenesis, tumor growth, and metastatic progression. It is essential to understand these mechanisms in order to create novel cancer treatments and prognostic models.

Role of Biomarkers in Cancer: Biomarkers are biological indicators that can reveal crucial information about cancer's presence, type, and progression. This session will focus on the growing role of biomarkers in precision oncology, where treatment is tailored to individual patient records based on biomarker data.

The "Types and Causes of Cancer" session offers a comprehensive overview of the various types of cancer and the factors that contribute to their development. This session will explore the various types of cancer, their characteristics, and the risk factors that increase the likelihood of cancer occurrence.